甘胺酸市場：型態(tài)、類型和應用劃分 - 2024-2030 年全球預測

預計2023年甘胺酸市場規(guī)模為15.3億美元，預計2024年將達16.2億美元，2030年將達到22.5億美元，復合年增長率為5.58%。甘氨酸鹽，通常稱為甘氨酸螯合物，是透過甘氨酸（一種氨基酸）與金屬離子結合的螯合過程產生的。甘氨酸鹽市場包括甘氨酸鹽的生產和銷售，甘氨酸鹽是一種螯合礦物質，通常用作營養(yǎng)和製藥應用的添加劑。消費者健康意識的提高、對礦物質強化營養(yǎng)補充的需求增加食品甘氨酸在動物飼料領域的應用不斷擴大正在推動市場成長。原材料價格的波動、替代產品的可用性以及與甘氨酸相關的副作用可能會限制市場開拓。新型甘胺酸製劑的創(chuàng)新將為市場拓展提供新的可能性。此外，甘胺酸循環(huán)製程在沼氣升級的新興應用預計將創(chuàng)造市場成長機會。主要市場統(tǒng)計基準年[2023]15.3億美元預測年份[2024]16.2億美元預測年份[2030]22.5億美元復合年增長率（%）5.58%干燥的甘氨酸鹽型態(tài)在各種環(huán)境條件下都很穩(wěn)定，從而增加了其多功能性。干甘氨酸鹽是甘氨酸鹽的固態(tài)形式，常用于製藥、個人護理和營養(yǎng)領域。當很重要的保質期或需要精確劑量時是首選。當考慮穩(wěn)定性時，也優(yōu)選干法，因為它們比液體更不易劣化。液體甘氨酸鹽是水溶液或懸浮液，主要用于易于整合到液體配方中，例如飲料和液體補充品。這種型態(tài)通常被選用于需要快速吸收或干燥型態(tài)存在溶解度問題的應用。甘氨酸鎂的需求量不斷增加，因為它以放鬆肌肉和緩解壓力而聞名。甘氨酸鈣是一種流行的螯合礦物質補充品，主要用于促進鈣的吸收和支持骨骼健康。它比含有碳酸鈣的傳統(tǒng)鈣補充品具有更高的生物有效性，使其成為胃酸低和尋求更有效吸收的人的首選。甘氨酸銅用作營養(yǎng)補充和飼料添加劑，提供酶過程和維持健康的免疫系統(tǒng)所需的必需微量元素。甘氨酸銅對于銅缺乏癥和動物飼料強化至關重要。甘氨酸鎂以其優(yōu)異的吸收率和健胃作用而聞名，可以幫助放鬆肌肉、減輕壓力、提高睡眠品質。甘氨酸錳在人類和動物飲食中用作營養(yǎng)成分，有助于各種代謝過程和結締組織的形成。甘氨酸鈉主要用于個人護理行業(yè)，在各種護膚產品中充當皮膚調理劑和緩衝劑。甘氨酸鈉因其溫和和舒緩皮膚的特性而被化妝品配方設計師用于針對敏感肌膚的產品中。甘氨酸鋅因其在支持免疫系統(tǒng)、皮膚健康和蛋白質合成方面的重要作用而被選中。其優(yōu)異的生物利用度使其成為首選的鋅補充品。甘氨酸作為刺激性化學物質的替代品在個人保健產品中的潛力不斷增長甘氨酸作為飼料添加劑，由于其高生物利用度，主要用作動物營養(yǎng)中的礦物質補充品。這些螯合化合物可改善動物的礦物質狀況，進而促進生長、生產力和整體健康。常見類型包括甘氨酸鎂、鋅、銅和甘氨酸錳?；谛枨蟮钠弥赜谔岣呱笃焚|和產量，甘胺酸比非螯合礦物質更受青睞，因為甘胺酸具有更好的吸收性和更低的環(huán)境影響。甘氨酸用于促進快速生長和骨骼發(fā)育。在食品工業(yè)中，甘氨酸鹽被用作添加劑，以豐富食品和飲料的必需礦物質。甘胺酸的生物利用度可改善乳製品、谷類和嬰兒奶粉奶粉等產品的營養(yǎng)狀況。消費者對機能性食品的偏好不斷增加，對甘胺酸作為食品添加物的需求也隨之增加。甘氨酸鹽非常安全，是保持食品味道和穩(wěn)定性的首選。由于其親膚特性，甘胺酸在個人保健產品中有著重要的應用。用于香皂、洗髮精、護膚品等配方中，提供溫和、溫和的清洗效果并穩(wěn)定泡沫。在製藥和營養(yǎng)補充食品，甘胺酸鹽被用作食品營養(yǎng)補充的關鍵成分，以增強礦物質供應并支持整體健康。區(qū)域洞察美國因其先進的農業(yè)技術和飼料工業(yè)，廣泛使用甘胺酸作為添加劑，是甘胺酸的主要消費國之一。大型個人護理和製藥公司的存在也導致了對甘氨酸的巨大需求，以改進產品配方。南美洲擁有大量的牲畜種群和龐大的農業(yè)部門，因此甘氨酸的使用機會很多。亞太地區(qū)（APAC）甘胺酸市場成長迅速，其中中國和印度是主要貢獻者。這種擴張是由于該地區(qū)肉類消費的增加、健康意識的增強以及個人護理行業(yè)的快速增長。此外，該地區(qū)龐大的農業(yè)部門為甘胺酸的應用提供了充足的機會，以提高作物產量和土壤健康。歐洲國家對飼料添加劑和個人護理成分有嚴格的規(guī)定，這導致采用更高品質的甘胺酸鹽。完善的醫(yī)療保健系統(tǒng)的存在以及消費者對健康和營養(yǎng)意識的提高正在推動歐洲市場的擴張。中東和非洲市場仍然是一個新興市場，經濟多元化的努力和個人保健產品供應的增加影響著潛力。FPNV定位矩陣FPNV定位矩陣對于評估甘胺酸市場至關重要。我們檢視與業(yè)務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。市場占有率分析市場占有率分析是一種綜合工具，可以對甘胺酸市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場占有率時面臨的挑戰(zhàn)。此外，該分析還提供了對該行業(yè)競爭特征的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特征等因素。詳細程度的提高使供應商能夠做出更明智的決策并制定有效的策略，從而在市場上獲得競爭優(yōu)勢。本報告在以下方面提供了寶貴的見解：1.市場滲透率：提供有關主要企業(yè)所服務的市場的全面資訊。2.市場開拓：我們深入研究利潤豐厚的新興市場，并分析其在成熟細分市場的滲透率。3.市場多元化：提供有關新產品發(fā)布、開拓地區(qū)、最新發(fā)展和投資的詳細資訊。4.競爭評估及資訊：對主要企業(yè)的市場占有率、策略、產品、認證、監(jiān)管狀況、專利狀況、製造能力等進行綜合評估。5.產品開發(fā)與創(chuàng)新：提供對未來技術、研發(fā)活動和突破性產品開發(fā)的見解。本報告解決了以下關鍵問題：更多詳情，請W:chenyu-zl，獲取報告樣品和報價汽車行業(yè)分析專家，8年汽車行業(yè)研究經驗，邏輯性強，數據敏感度較高。合作伙伴：道依茨、采埃孚、大陸集團、三菱重工、沃爾沃、米其林等。1.甘胺酸市場的市場規(guī)模和預測是多少？2.甘胺酸市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？3.甘胺酸市場的技術趨勢和法規(guī)結構是什么？4.甘胺酸市場主要供應商的市場占有率是多少？5.進入甘胺酸市場適合的型態(tài)和策略手段是什么？目錄第一章前言第二章調查方法第三章執(zhí)行摘要第四章市場概況第五章市場洞察市場動態(tài)促進因素消費者健康意識的提高和對礦物質強化營養(yǎng)補充食品的需求不斷增加擴大甘胺酸在動物飼料領域的應用抑制因素原物料價格波動機會新型甘胺酸鹽配方的創(chuàng)新甘胺酸循環(huán)製程在沼氣提質的新應用任務替代產品的可用性以及與甘胺酸相關的副作用市場區(qū)隔分析型態(tài):擴大使用干燥甘氨酸鹽以在各種環(huán)境條件下提供穩(wěn)定性類型：甘氨酸鎂由于其具有放鬆肌肉和減輕壓力的聲譽而受到很高的需求。應用：擴大甘氨酸在個人保健產品中作為更刺激化學替代品的潛力市場擾動分析波特五力分析價值煉和關鍵路徑分析價格分析技術分析專利分析貿易分析法規(guī)結構分析第六章甘胺酸市場：型態(tài)干燥液體第七章甘胺酸市場：依類型甘氨酸鈣甘氨酸銅甘胺酸鎂甘氨酸錳甘氨酸鈉甘氨酸鋅第八章甘胺酸市場：依應用分類飼料添加劑食品添加物個人保健產品藥品和營養(yǎng)補充食品第九章美洲甘氨酸市場阿根廷巴西加拿大墨西哥美國第10章亞太甘氨酸市場澳洲中國印度印尼日本馬來西亞菲律賓新加坡韓國臺灣泰國越南第十一章歐洲、中東和非洲甘胺酸市場丹麥埃及芬蘭法國德國以色列義大利荷蘭奈及利亞挪威波蘭卡達俄羅斯沙烏地阿拉伯南非西班牙瑞典瑞士土耳其阿拉伯聯(lián)合大公國英國第十二章競爭格局2023年市場占有率分析FPNV定位矩陣，2023競爭情境分析TraceMinerals在酵母天然品博覽會上推出七種新產品PlanetOrganic推出自有品牌補充品系列戰(zhàn)略分析和建議第13章競爭產品組合主要企業(yè)簡介主要產品系列簡介目錄圖表ProductCode:MRR-43539E5D2BD6[185PagesReport]TheGlycinatesMarketsizewasestimatedatUSD1.53billionin2023andexpectedtoreachUSD1.62billionin2024,ataCAGR5.58%toreachUSD2.25billionby2030.Glycinates,commonlyknownasglycinechelates,areproducedthroughachelationprocessthatinvolvesthebondingofglycine,anaminoacid,withmetalions.Theglycinatesmarketcomprisestheproductionandsaleofglycinates,achelatedmineraloftenusedasanadditiveinnutritionalandpharmaceuticalapplications.Risinghealthconsciousnessamongconsumers,theincreasingdemandformineral-enricheddietarysupplements,andthegrowingapplicationofglycinatesintheanimalfeedsectorfostermarketgrowth.Fluctuatingrawmaterialprices,availabilityofsubstituteproducts,andadverseeffectsassociatedwithglycinatescanlimitmarketdevelopment.Innovationsinnewglycinate-basedformulationswilllikelypresentnewpossibilitiesformarketexpansion.Inaddition,emergingapplicationsofglycinate-loopingprocessesforbiogasupgradingareexpectedtocreategrowthopportunitiesinthemarket.KEYMARKETSTATISTICSBaseYear[2023]USD1.53billionEstimatedYear[2024]USD1.62billionForecastYear[2030]USD2.25billionCAGR(%)5.58%Form:ExpandingusageofdryglycinatesasitprovidesstabilityinvariousenvironmentalconditionsDryglycinatesarethesolidformofglycinates,whicharecommonlyusedinthepharmaceutical,personalcare,andnutritionalsectors.Theyarepreferredwhenthelongevityoftheshelflifeisvitalandwhenprecisedosingisrequired.Thedryformisalsofavoredwhenstabilityisaconcern,asitislesspronetodegradationthanliquidforms.Liquidglycinatesareaqueoussolutionsorsuspensionsthatareprimarilyutilizedfortheireaseofintegrationintoliquid-basedformulationssuchasbeveragesandliquidsupplements.Thisformisoftenchosenforapplicationswhererapidabsorptionisdesirableorwhentherearesolubilitychallengeswiththedryform.Type:IncreasingdemandformagnesiumglycinateduetoitsrenownedinmusclerelaxationandstressreductionCalciumglycinateisapopularchelatedmineralsupplementusedprimarilyforenhancingcalciumuptakeandsupportingbonehealth.Itshighbioavailabilitycomparedtotraditionalcalciumsupplements,includingcalciumcarbonate,makesitapreferredchoiceforindividualswithlowstomachacidorthoseseekingmoreefficientabsorption.Copperglycinateisusedasadietarysupplementandfeedadditive,providinganessentialtraceelementneededforenzymaticprocessesandthemaintenanceofimmunesystemhealth.Copperglycinateisessentialforindividualsdealingwithcopperdeficienciesandforenhancinganimalfeednutritionalquality.Magnesiumglycinateisrenownedforitsrolesinmusclerelaxation,stressreduction,andimprovingsleepquality,owingtoitsexcellentabsorptionratesandgentleeffectonthestomach.Manganeseglycinateisutilizedasanutritionalcomponentbothinhumanandanimaldiets,assistinginvariousmetabolicprocessesandtheformationofconnectivetissue.Primarilyusedinthepersonalcareindustry,sodiumglycinateactsasaskinconditioningagentandbufferingagentinvariousskincareproducts.Sodiumglycinateisutilizedbycosmeticformulatorsforproductstargetingsensitiveskinduetoitsmildnatureandskin-soothingproperties.Zincglycinateischosenforitspivotalroleinsupportingtheimmunesystem,skinhealth,andproteinsynthesis.Itsexcellentbioavailabilitymakesitafavorablezincsupplementform.Application:GrowingpotentialofglycinatesinpersonalcareproductsasanalternativetoharsherchemicalsGlycinatesasfeedadditivesareprimarilyutilizedfortheirhighbioavailabilityasmineralsupplementsinanimalnutrition.Thesechelatedcompoundsimprovethemineralstatusofanimals,leadingtoenhancedgrowth,productivity,andoverallhealth.Commontypesincludemagnesium,zinc,copper,andmanganeseglycinate.Withtheneed-basedpreferencefocusingonimprovinglivestockqualityandyield,glycinatesarepreferredovernon-chelatedmineralsduetotheirbetterabsorptionratesandlowerenvironmentalimpact.Thedemandisparticularlyhighinpoultryandswineapplications,whereglycinatesareusedtofosterquickergrowthandbonedevelopment.Inthefoodindustry,glycinatesareusedasadditivestofortifyfoodsandbeverageswithessentialminerals.Thebioavailabilityofglycinatesenhancesthenutritionalprofileofproducts,includingdairy,cereals,andinfantformula.Consumers'increasingpreferenceforfunctionalfoodsdrivestheneedforglycinatesasafoodadditive.Theyareconsideredsafeandarefavoredformaintainingthetasteandstabilityofthefoodproducts.Glycinatesfindsignificantapplicationsinpersonalcareproductsduetotheirskin-friendlyproperties.Theyareusedinformulationsforsoaps,shampoos,andskincareproductstoofferamildandgentlecleansingeffectandtostabilizefoam.Inthepharmaceutical&nutraceuticalindustry,glycinatesareusedasakeycomponentindietarysupplementstoenhancemineraldeliveryandsupportoverallhealthandwellness.RegionalInsightsTheUnitedStatesisamongthemajorconsumersofglycinatesduetoitsadvancedagriculturaltechnologyandsubstantialfeedindustry,whichextensivelyusesglycinatesasadditives.Thepresenceofleadingpersonalcareandpharmaceuticalcompaniesalsocontributestosignificantglycinatesdemandforimprovedproductformulations.AcrossSouthAmerica,theprominentlivestockpopulationandlargeagriculturesectorprovideconsiderableopportunitiesfortheuseofglycinates.TheAsia-Pacific(APAC)iswitnessingrapidgrowthintheglycinatesmarket,withChinaandIndiabeingthemajorcontributors.Theexpansionisattributedtorisingmeatconsumption,growinghealthconsciousness,andtheburgeoningpersonalcareindustryintheregion.Additionally,theregion'slargeagriculturalsectorprovidesampleopportunitiesforglycinateapplicationinenhancingcropyieldsandsoilhealth.Europeancountrieshavestringentregulationsregardingfeedadditivesandpersonalcareingredients,whichhasledtotheadoptionofhigh-qualityglycinates.Thepresenceofwell-establishedhealthcaresystemsandgrowingconsumerawarenessabouthealthandnutritionaidtheEuropeanmarket'sexpansion.TheMiddleEasternandAfricanmarketsarestilldeveloping,withthepotentialinfluencedbyeconomicdiversificationeffortsandtheincreasingavailabilityofpersonalcareproducts.FPNVPositioningMatrixTheFPNVPositioningMatrixispivotalinevaluatingtheGlycinatesMarket.Itoffersacomprehensiveassessmentofvendors,examiningkeymetricsrelatedtoBusinessStrategyandProductSatisfaction.Thisin-depthanalysisempowersuserstomakewell-informeddecisionsalignedwiththeirrequirements.Basedontheevaluation,thevendorsarethencategorizedintofourdistinctquadrantsrepresentingvaryinglevelsofsuccess:Forefront(F),Pathfinder(P),Niche(N),orVital(V).MarketShareAnalysisTheMarketShareAnalysisisacomprehensivetoolthatprovidesaninsightfulandin-depthexaminationofthecurrentstateofvendorsintheGlycinatesMarket.Bymeticulouslycomparingandanalyzingvendorcontributionsintermsofoverallrevenue,customerbase,andotherkeymetrics,wecanoffercompaniesagreaterunderstandingoftheirperformanceandthechallengestheyfacewhencompetingformarketshare.Additionally,thisanalysisprovidesvaluableinsightsintothecompetitivenatureofthesector,includingfactorssuchasaccumulation,fragmentationdominance,andamalgamationtraitsobservedoverthebaseyearperiodstudied.Withthisexpandedlevelofdetail,vendorscanmakemoreinformeddecisionsanddeviseeffectivestrategiestogainacompetitiveedgeinthemarket.KeyCompanyProfilesThereportdelvesintorecentsignificantdevelopmentsintheGlycinatesMarket,highlightingleadingvendorsandtheirinnovativeprofiles.TheseincludeABEnterprises,AdityaChemicals,AjinomotoCo.,Inc.,BalchemInc.,BASFSE,ChaitanyaBiologicalsPvt.Ltd,ClariantAG,ColonialChemicalInc.,GalaxySurfactantsLimited,Innospec,JHBiotechInc.,JostChemicalCo.,NovotechNutraceuticals,Inc.,PatImpexPrivateLimited,PHARMAVITApS,ShijiazhuangDonghuaJinlongChemicalIndustryCo.,Ltd.,SinoLionUSA,SolvayS.A.,SuchemIndustries,SurfaceChemicalIndustryCo.Ltd.,andUNOVETCHEM.MarketSegmentation&CoverageThisresearchreportcategorizestheGlycinatesMarkettoforecasttherevenuesandanalyzetrendsineachofthefollowingsub-markets:FormDryLiquidTypeCalciumGlycinateCopperGlycinateMagnesiumGlycinateManganeseGlycinateSodiumGlycinateZincGlycinateApplicationFeedAdditivesFoodAdditivesPersonalCareProductsPharmaceuticals&NutraceuticalsRegionAmericasArgentinaBrazilCanadaMexicoUnitedStatesCaliforniaFloridaIllinoisNewYorkOhioPennsylvaniaTexasAsia-PacificAustraliaChinaIndiaIndonesiaJapanMalaysiaPhilippinesSingaporeSouthKoreaTaiwanThailandVietnamEurope,MiddleEast&AfricaDenmarkEgyptFinlandFranceGermanyIsraelItalyNetherlandsNigeriaNorwayPolandQatarRussiaSaudiArabiaSouthAfricaSpainSwedenSwitzerlandTurkeyUnitedArabEmiratesUnitedKingdomThereportoffersvaluableinsightsonthefollowingaspects:1.MarketPenetration:Itpresentscomprehensiveinformationonthemarketprovidedbykeyplayers.2.MarketDevelopment:Itdelvesdeepintolucrativeemergingmarketsandanalyzesthepenetrationacrossmaturemarketsegments.3.MarketDiversification:Itprovidesdetailedinformationonnewproductlaunches,untappedgeographicregions,recentdevelopments,andinvestments.4.CompetitiveAssessment&Intelligence:Itconductsanexhaustiveassessmentofmarketshares,strategies,products,certifications,regulatoryapprovals,patentlandscape,andmanufacturingcapabilitiesoftheleadingplayers.5.ProductDevelopment&Innovation:Itoffersintelligentinsightsonfuturetechnologies,R&Dactivities,andbreakthroughproductdevelopments.Thereportaddresseskeyquestionssuchas:1.WhatisthemarketsizeandforecastoftheGlycinatesMarket?2.Whichproducts,segments,applications,andareasshouldoneconsiderinvestinginovertheforecastperiodintheGlycinatesMarket?3.WhatarethetechnologytrendsandregulatoryframeworksintheGlycinatesMarket?4.WhatisthemarketshareoftheleadingvendorsintheGlycinatesMarket?5.WhichmodesandstrategicmovesaresuitableforenteringtheGlycinatesMarket?TableofContents1.Preface1.1.ObjectivesoftheStudy1.2.MarketSegmentation&Coverage1.3.YearsConsideredfortheStudy1.4.Currency&Pricing1.5.Language1.6.Stakeholders2.ResearchMethodology2.1.Define:ResearchObjective2.2.Determine:ResearchDesign2.3.Prepare:ResearchInstrument2.4.Collect:DataSource2.5.Analyze:DataInterpretation2.6.Formulate:DataVerification2.7.Publish:ResearchReport2.8.Repeat:ReportUpdate3.ExecutiveSummary4.MarketOverview5.MarketInsights5.1.MarketDynamics5.1.1.Drivers.Risinghealthconsciousnessamongconsumersandtheincreasingdemandformineral-enricheddietarysupplements.Growingapplicationofglycinatesintheanimalfeedsector5.1.2.Restraints.Fluctuatingrawmaterialprices5.1.3.Opportunities.Innovationsinnewglycinate-basedformulations.Emergingapplicationsofglycinate-loopingprocessesforbiogasupgrading5.1.4.Challenges.Availabilityofsubstituteproductsandadverseeffectsassociatedwithglycinates5.2.MarketSegmentationAnalysis5.2.1.Form:Expandingusageofdryglycinatesasitprovidesstabilityinvariousenvironmentalconditions5.2.2.Type:Increasingdemandformagnesiumglycinateduetoitsrenownedinmusclerelaxationandstressreduction5.2.3.Application:Growingpotentialofglycinatesinpersonalcareproductsasanalternativetoharsherchemicals5.3.MarketDisruptionAnalysis5.4.Porter'sFiveForcesAnalysis5.4.1.ThreatofNewEntrants5.4.2.ThreatofSubstitutes5.4.3.BargainingPowerofCustomers5.4.4.BargainingPowerofSuppliers5.4.5.IndustryRivalry5.5.ValueChain&CriticalPathAnalysis5.6.PricingAnalysis5.7.TechnologyAnalysis5.8.PatentAnalysis5.9.TradeAnalysis5.10.RegulatoryFrameworkAnalysis6.GlycinatesMarket,byForm6.1.Introduction6.2.Dry6.3.Liquid7.GlycinatesMarket,byType7.1.Introduction7.2.CalciumGlycinate7.3.CopperGlycinate7.4.MagnesiumGlycinate7.5.ManganeseGlycinate7.6.SodiumGlycinate7.7.ZincGlycinate8.GlycinatesMarket,byApplication8.1.Introduction8.2.FeedAdditives8.3.FoodAdditives8.4.PersonalCareProducts8.5.Pharmaceuticals&Nutraceuticals9.AmericasGlycinatesMarket9.1.Introduction9.2.Argentina9.3.Brazil9.4.Canada9.5.Mexico9.6.UnitedStates10.Asia-PacificGlycinatesMarket10.1.Introduction10.2.Australia10.3.China10.4.India10.5.Indonesia10.6.Japan10.7.Malaysia10.8.Philippines10.9.Singapore10.10.SouthKorea10.11.Taiwan10.12.Thailand10.13.Vietnam11.Europe,MiddleEast&AfricaGlycinatesMarket11.1.Introduction11.2.Denmark11.3.Egypt11.4.Finland11.5.France11.6.Germany11.7.Israel11.8.Italy11.9.Netherlands11.10.Nigeria11.11.Norway11.12.Poland11.13.Qatar11.14.Russia11.15.SaudiArabia11.16.SouthAfrica11.17.Spain11.18.Sweden11.19.Switzerland11.20.Turkey11.21.UnitedArabEmirates11.22.UnitedKingdom12.CompetitiveLandscape12.1.MarketShareAnalysis,202312.2.FPNVPositioningMatrix,202312.3.CompetitiveScenarioAnalysis12.3.1.TraceMineralstoDebutSevenNewProductsatNaturalProductsExpoEast12.3.2.PlanetOrganicLaunchesOwn-BrandSupplementsLine12.4.StrategyAnalysis&Recommendation13.CompetitivePortfolio13.1.KeyCompanyProfiles13.2.KeyProductPortfolio簡介目錄圖表LISTOFFIGURESFIGURE1.GLYCINATESMARKETRESEARCHPROCESSFIGURE2.GLYCINATESMARKETSIZE,2023VS2030FIGURE3.GLOBALGLYCINATESMARKETSIZE,2018-2030(USDMILLION)FIGURE4.GLOBALGLYCINATESMARKETSIZE,BYREGION,2023VS2030(%)FIGURE5.GLOBALGLYCINATESMARKETSIZE,BYREGION,2023VS2024VS2030(USDMILLION)FIGURE6.GLYCINATESMARKETDYNAMICSFIGURE7.GLOBALGLYCINATESMARKETSIZE,BYFORM,2023VS2030(%)FIGURE8.GLOBALGLYCINATESMARKETSIZE,BYFORM,2023VS2024VS2030(USDMILLION)FIGURE9.GLOBALGLYCINATESMARKETSIZE,BYTYPE,2023VS2030(%)FIGURE10.GLOBALGLYCINATESMARKETSIZE,BYTYPE,2023VS2024VS2030(USDMILLION)FIGURE11.GLOBALGLYCINATESMARKETSIZE,BYAPPLICATION,2023VS2030(%)FIGURE12.GLOBALGLYCINATESMARKETSIZE,BYAPPLICATION,2023VS2024VS2030(USDMILLION)FIGURE13.AMERICASGLYCINATESMARKETSIZE,BYCOUNTRY,2023VS2030(%)FIGURE14.AMERICASGLYCINATESMARKETSIZE,BYCOUNTRY,2023VS2024VS2030(USDMILLION)FIGURE15.UNITEDSTATESGLYCINATESMARKETSIZE,BYSTATE,2023VS2030(%)FIGURE16.UNITEDSTATESGLYCINATESMARKETSIZE,BYSTATE,2023VS2024VS2030(USDMILLION)FIGURE17.ASIA-PACIFICGLYCINATESMARKETSIZE,BYCOUNTRY,2023VS2030(%)FIGURE18.ASIA-PACIFICGLYCINATESMARKETSIZE,BYCOUNTRY,2023VS2024VS2030(USDMILLION)FIGURE19.EUROPE,MIDDLEEAST&AFRICAGLYCINATESMARKETSIZE,BYCOUNTRY,2023VS2030(%)FIGURE20.EUROPE,MIDDLEEAST&AFRICAGLYCINATESMARKETSIZE,BYCOUNTRY,2023VS2024VS2030(USDMILLION)FIGURE21.GLYCINATESMARKETSHARE,BYKEYPLAYER,2023FIGURE22.GLYCINATESMARKET,FPNVPOSITIONINGMATRIX,2023LISTOFTABLESTABLE1.GLYCINATESMARKETSEGMENTATION&COVERAGETABLE2.UNITEDSTATESDOLLAREXCHANGERATE,2018-2023TABLE3.GLOBALGLYCINATESMARKETSIZE,2018-2023(USDMILLION)TABLE4.GLOBALGLYCINATESMARKETSIZE,2024-2030(USDMILLION)TABLE5.GLOBALGLYCINATESMARKETSIZE,BYREGION,2018-2023(USDMILLION)TABLE6.GLOBALGLYCINATESMARKETSIZE,BYREGION,2024-2030(USDMILLION)TABLE7.GLOBALGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE8.GLOBALGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE9.GLOBALGLYCINATESMARKETSIZE,BYDRY,BYREGION,2018-2023(USDMILLION)TABLE10.GLOBALGLYCINATESMARKETSIZE,BYDRY,BYREGION,2024-2030(USDMILLION)TABLE11.GLOBALGLYCINATESMARKETSIZE,BYLIQUID,BYREGION,2018-2023(USDMILLION)TABLE12.GLOBALGLYCINATESMARKETSIZE,BYLIQUID,BYREGION,2024-2030(USDMILLION)TABLE13.GLOBALGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE14.GLOBALGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE15.GLOBALGLYCINATESMARKETSIZE,BYCALCIUMGLYCINATE,BYREGION,2018-2023(USDMILLION)TABLE16.GLOBALGLYCINATESMARKETSIZE,BYCALCIUMGLYCINATE,BYREGION,2024-2030(USDMILLION)TABLE17.GLOBALGLYCINATESMARKETSIZE,BYCOPPERGLYCINATE,BYREGION,2018-2023(USDMILLION)TABLE18.GLOBALGLYCINATESMARKETSIZE,BYCOPPERGLYCINATE,BYREGION,2024-2030(USDMILLION)TABLE19.GLOBALGLYCINATESMARKETSIZE,BYMAGNESIUMGLYCINATE,BYREGION,2018-2023(USDMILLION)TABLE20.GLOBALGLYCINATESMARKETSIZE,BYMAGNESIUMGLYCINATE,BYREGION,2024-2030(USDMILLION)TABLE21.GLOBALGLYCINATESMARKETSIZE,BYMANGANESEGLYCINATE,BYREGION,2018-2023(USDMILLION)TABLE22.GLOBALGLYCINATESMARKETSIZE,BYMANGANESEGLYCINATE,BYREGION,2024-2030(USDMILLION)TABLE23.GLOBALGLYCINATESMARKETSIZE,BYSODIUMGLYCINATE,BYREGION,2018-2023(USDMILLION)TABLE24.GLOBALGLYCINATESMARKETSIZE,BYSODIUMGLYCINATE,BYREGION,2024-2030(USDMILLION)TABLE25.GLOBALGLYCINATESMARKETSIZE,BYZINCGLYCINATE,BYREGION,2018-2023(USDMILLION)TABLE26.GLOBALGLYCINATESMARKETSIZE,BYZINCGLYCINATE,BYREGION,2024-2030(USDMILLION)TABLE27.GLOBALGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2023(USDMILLION)TABLE28.GLOBALGLYCINATESMARKETSIZE,BYAPPLICATION,2024-2030(USDMILLION)TABLE29.GLOBALGLYCINATESMARKETSIZE,BYFEEDADDITIVES,BYREGION,2018-2023(USDMILLION)TABLE30.GLOBALGLYCINATESMARKETSIZE,BYFEEDADDITIVES,BYREGION,2024-2030(USDMILLION)TABLE31.GLOBALGLYCINATESMARKETSIZE,BYFOODADDITIVES,BYREGION,2018-2023(USDMILLION)TABLE32.GLOBALGLYCINATESMARKETSIZE,BYFOODADDITIVES,BYREGION,2024-2030(USDMILLION)TABLE33.GLOBALGLYCINATESMARKETSIZE,BYPERSONALCAREPRODUCTS,BYREGION,2018-2023(USDMILLION)TABLE34.GLOBALGLYCINATESMARKETSIZE,BYPERSONALCAREPRODUCTS,BYREGION,2024-2030(USDMILLION)TABLE35.GLOBALGLYCINATESMARKETSIZE,BYPHARMACEUTICALS&NUTRACEUTICALS,BYREGION,2018-2023(USDMILLION)TABLE36.GLOBALGLYCINATESMARKETSIZE,BYPHARMACEUTICALS&NUTRACEUTICALS,BYREGION,2024-2030(USDMILLION)TABLE37.AMERICASGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE38.AMERICASGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE39.AMERICASGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE40.AMERICASGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE41.AMERICASGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2023(USDMILLION)TABLE42.AMERICASGLYCINATESMARKETSIZE,BYAPPLICATION,2024-2030(USDMILLION)TABLE43.AMERICASGLYCINATESMARKETSIZE,BYCOUNTRY,2018-2023(USDMILLION)TABLE44.AMERICASGLYCINATESMARKETSIZE,BYCOUNTRY,2024-2030(USDMILLION)TABLE45.ARGENTINAGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE46.ARGENTINAGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE47.ARGENTINAGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE48.ARGENTINAGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE49.ARGENTINAGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2023(USDMILLION)TABLE50.ARGENTINAGLYCINATESMARKETSIZE,BYAPPLICATION,2024-2030(USDMILLION)TABLE51.BRAZILGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE52.BRAZILGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE53.BRAZILGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE54.BRAZILGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE55.BRAZILGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2023(USDMILLION)TABLE56.BRAZILGLYCINATESMARKETSIZE,BYAPPLICATION,2024-2030(USDMILLION)TABLE57.CANADAGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE58.CANADAGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE59.CANADAGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE60.CANADAGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE61.CANADAGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2023(USDMILLION)TABLE62.CANADAGLYCINATESMARKETSIZE,BYAPPLICATION,2024-2030(USDMILLION)TABLE63.MEXICOGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE64.MEXICOGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE65.MEXICOGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE66.MEXICOGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE67.MEXICOGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2023(USDMILLION)TABLE68.MEXICOGLYCINATESMARKETSIZE,BYAPPLICATION,2024-2030(USDMILLION)TABLE69.UNITEDSTATESGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE70.UNITEDSTATESGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE71.UNITEDSTATESGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE72.UNITEDSTATESGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE73.UNITEDSTATESGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2023(USDMILLION)TABLE74.UNITEDSTATESGLYCINATESMARKETSIZE,BYAPPLICATION,2024-2030(USDMILLION)TABLE75.UNITEDSTATESGLYCINATESMARKETSIZE,BYSTATE,2018-2023(USDMILLION)TABLE76.UNITEDSTATESGLYCINATESMARKETSIZE,BYSTATE,2024-2030(USDMILLION)TABLE77.ASIA-PACIFICGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE78.ASIA-PACIFICGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE79.ASIA-PACIFICGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE80.ASIA-PACIFICGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE81.ASIA-PACIFICGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2023(USDMILLION)TABLE82.ASIA-PACIFICGLYCINATESMARKETSIZE,BYAPPLICATION,2024-2030(USDMILLION)TABLE83.ASIA-PACIFICGLYCINATESMARKETSIZE,BYCOUNTRY,2018-2023(USDMILLION)TABLE84.ASIA-PACIFICGLYCINATESMARKETSIZE,BYCOUNTRY,2024-2030(USDMILLION)TABLE85.AUSTRALIAGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE86.AUSTRALIAGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE87.AUSTRALIAGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE88.AUSTRALIAGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE89.AUSTRALIAGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2023(USDMILLION)TABLE90.AUSTRALIAGLYCINATESMARKETSIZE,BYAPPLICATION,2024-2030(USDMILLION)TABLE91.CHINAGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE92.CHINAGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE93.CHINAGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE94.CHINAGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE95.CHINAGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2023(USDMILLION)TABLE96.CHINAGLYCINATESMARKETSIZE,BYAPPLICATION,2024-2030(USDMILLION)TABLE97.INDIAGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE98.INDIAGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE99.INDIAGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE100.INDIAGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE101.INDIAGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2